日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Editorial: Recombinant microbes-mediated cancer immunotherapy

社论:重组微生物介导的癌症免疫疗法

Wechman, Stephen; Jala, Venkatakrishna Rao; Bermudez-Humaran, Luis G; Gomez-Gutierrez, Jorge G

Vascular mimicry: Triggers, molecular interactions and in vivo models

血管模拟:触发因素、分子相互作用和体内模型

Wechman, Stephen L; Emdad, Luni; Sarkar, Devanand; Das, Swadesh K; Fisher, Paul B

The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacy

JNK磷酸化作为分子靶点在增强腺病毒复制、溶瘤和癌症治疗功效中的作用

Stephen L Wechman, Xiao-Mei Rao, Jorge G Gomez-Gutierrez, Heshan Sam Zhou, Kelly M McMasters

Adenovirus Lacking E1b Efficiently Induces Cytopathic Effect in HPV-16-Positive Murine Cancer Cells via Virus Replication and Apoptosis

缺乏E1b的腺病毒通过病毒复制和细胞凋亡有效诱导HPV-16阳性小鼠癌细胞的细胞病变效应

Martinez-Jaramillo, Elvis; Garza-Morales, Rodolfo; Wechman, Stephen L; Montes de Oca-Luna, Roberto; Saucedo-Cardenas, Odila; Shirwan, Haval; Yolcu, Esma; McMasters, Kelly M; Gomez-Gutierrez, Jorge G

New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor Activity

Beclin-1 的新见解:演变和泛恶性肿瘤抑制剂活性

Wechman, Stephen L; Pradhan, Anjan K; DeSalle, Rob; Das, Swadesh K; Emdad, Luni; Sarkar, Devanand; Fisher, Paul B

Adenovirus with DNA Packaging Gene Mutations Increased Virus Release

腺病毒DNA包装基因突变导致病毒释放增加

Wechman, Stephen L; Rao, Xiao-Mei; McMasters, Kelly M; Zhou, Heshan Sam

Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo

溶瘤腺病毒与替莫唑胺联合治疗可增强体外和体内肺癌病毒疗法的疗效。

Gomez-Gutierrez, Jorge G; Nitz, Jonathan; Sharma, Rajesh; Wechman, Stephen L; Riedinger, Eric; Martinez-Jaramillo, Elvis; Sam Zhou, Heshan; McMasters, Kelly M

Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice.

靶向细胞周期蛋白 E 过表达的溶瘤腺病毒抑制了同基因免疫功能正常小鼠的肿瘤生长

Cheng Pei-Hsin, Rao Xiao-Mei, Wechman Stephen L, Li Xiao-Feng, McMasters Kelly M, Zhou Heshan Sam